Botswana Tenofovir Oral HIV Prophylaxis Trial

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

March 31, 2007

Conditions
HIV Infection
Interventions
DRUG

Tenofovir Disoproxil Fumarate 300 mg daily

Trial Locations (2)

30333

Centers for Disease Control and Prevention, Atlanta

Unknown

BOTUSA HIV Prevention Research Unit, Francistown and Gaborone

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Botswana Ministry of Health

OTHER_GOV

collaborator

Gilead Sciences

INDUSTRY

lead

Centers for Disease Control and Prevention

FED